Transparency, trust, and understanding of relationships focused on patient well-being. Collaboration between the pharmaceutical industry and healthcare professionals and organizations in the development of innovative medicines has changed the course of many diseases. The disclosure of payments made to healthcare professionals and organizations strengthens trust in the ethical and impartial nature of treatment-related decisions.
Strategic Projects
Initiatives
Useful Links
News
02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...
Innovative Pharmaceutical Initiative – iF!
02/2021
EFPIA/iF! Code on Disclosure of Data 2016
Transparency, trust, and understanding of relationships focused on patient well-being
Transparency, trust, and understanding of relationships focused on patient well-being
Published
22. April 2016.
Source
Category
Tag
Latest News
02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...
02/2021
Cancer patients are dying from coronavirus – and many will bear the consequences...
02/2021
The annual survey titled “EFPIA Patients WAIT”, conducted by the European Federation of...
02/2021
European organizations involved in oncology health policies have committed to developing and promoting...
02/2021
Lung cancer in Europe kills almost as many people as breast, colorectal, and...
02/2021
Almost forty years ago, the first bone marrow transplant was performed at KBC...